October 14, 2024

Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO’s pharmacovigilance database – Nature.com

October 14, 2024

Patterns of progression in a contemporary cohort of 447 patients with smoldering multiple myeloma – Nature.com

October 14, 2024

Johnson & Johnson receives updated NICE recommendation for Tecvayli in multiple myeloma – PMLiVE

October 14, 2024

Mitigating AEs and Protecting QOL Following Talquetamab in Multiple Myeloma – Cancer Network

October 14, 2024

5-year survival rate for Korean multiple myeloma patients nearly doubles, yet access to new treatments still limited: IQVIA – KBR